BMRA
Biomerica Inc.
$2.71
-$0.08(-3.01%)
43
Overall
60
Value
18
Tech
52
Quality
Market Cap
$8.11M
Volume
12.92K
52W Range
$2.08 - $10.16
Target Price
$13.00
Order:
Income Statement
| Metric | Trend | Chart | 2015 May | 2016 May | 2017 May | 2018 May | 2019 May | 2020 May | 2021 May | 2022 May | 2023 May | 2024 May |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $5.0M | $5.1M | $5.8M | $5.6M | $5.2M | $6.7M | $7.2M | $18.9M | $5.3M | $5.4M | ||
| Total Revenue | $5.0M | $5.1M | $5.8M | $5.6M | $5.2M | $6.7M | $7.2M | $18.9M | $5.3M | $5.4M | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $-3.4M | $-3.6M | $-3.8M | $-3.8M | $-3.9M | $5.0M | $6.8M | $15.9M | $4.9M | $4.8M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $1.5M | $1.5M | $2.0M | $1.8M | $1.3M | $1.7M | $366.3K | $3.0M | $446.0K | $611.0K | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-2.2M | $-2.4M | $-3.0M | $-3.2M | $-3.7M | $4.2M | $7.9M | $7.5M | $7.7M | $7.0M | ||
| Research & Development | $733.6K | $780.3K | $1.1M | $1.4M | $1.7M | $1.9M | $2.2M | $1.8M | $1.6M | $1.5M | ||
| Research Expense | $733.6K | $780.3K | $1.1M | $1.4M | $1.7M | $1.9M | $2.2M | $1.8M | $1.6M | $1.5M | ||
| Selling, General & Administrative | $1.5M | $1.6M | $1.8M | $1.8M | $2.0M | $2.3M | $12.5M | $21.6M | $6.1M | $5.5M | ||
| Selling & Marketing Expenses | $1.5M | $1.6M | $1.8M | $1.8M | $2.0M | $174 | $6.8M | $15.9M | $156.0K | $101.0K | ||
| General & Administrative Expenses | -- | -- | $-2.9K | -- | -- | $2.3M | $5.7M | $5.7M | $6.1M | $5.5M | ||
| Promotion & Advertising | $-6.0K | $-2.0K | $-7.0K | $-1.0K | -- | $174 | $10.0K | $76.0K | $156.0K | $101.0K | ||
| Salaries & Wages | -- | -- | -- | $-18.5K | $-151.2K | -- | -- | -- | -- | -- | ||
| Depreciation & Amortization | $-178.2K | $-156.3K | $-144.9K | $-111.1K | $-101.2K | $105.3K | $105.0K | $339.0K | $84.0K | -- | ||
| Depreciation & Amortization | $-178.2K | $-156.3K | $-144.9K | $-111.1K | $-101.2K | $4.9M | $105.0K | $339.0K | $84.0K | -- | ||
| Amortization | $-75.1K | $-76.1K | $-74.3K | $-75.5K | $-61.7K | $168.7K | $295.0K | $239.0K | $165.0K | $212.0K | ||
| Other Operating Expenses | -- | -- | -- | -- | -- | -- | -- | $357.0K | $358.0K | $378.0K | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-670.6K | $-827.0K | $-954.6K | $-1.5M | $-2.4M | $-2.4M | $-7.5M | $-4.5M | $-7.2M | $-6.4M | ||
| EBITDA | $-393.2K | $-563.4K | $-689.1K | $-1.2M | $-2.2M | $-2.3M | $-7.1M | $-3.9M | $-6.7M | $-5.6M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | -- | $167 | $282 | $37 | $47 | $9 | $367 | -- | -- | -- | ||
| Interest Income Operating | -- | -- | -- | -- | -- | -- | -- | -- | $133.0K | $431.0K | ||
| Net Non-Operating Interest Income/Expense | -- | $-167 | $-282 | $-37 | $-47 | $-9 | $-367 | $-27.0K | $-133.0K | -- | ||
| Other Income/Expense | $-24.2K | $-31.1K | $-46.4K | $-47.8K | $-44.0K | $4.8M | $-66.9K | $-27.0K | $-1.0K | -- | ||
| Other Special Charges | $24.2K | $31.1K | $46.4K | $47.8K | $44.0K | $71.2K | $66.9K | $27.0K | $1.0K | -- | ||
| SPECIAL ITEMS | ||||||||||||
| Special Income Charges | -- | -- | -- | -- | -- | -- | -- | $-210.0K | -- | -- | ||
| Impairment of Capital Assets | -- | -- | -- | -- | -- | -- | -- | $210.0K | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-646.4K | $-795.8K | $-908.3K | $-1.4M | $-2.4M | $-2.7M | $-7.4M | $-4.5M | $-7.1M | $-5.9M | ||
| Pre-Tax Income | $-646.4K | $-796.0K | $-908.6K | $-1.4M | $-2.4M | $-2.3M | $-7.4M | $-4.5M | $-7.1M | $-5.9M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $-315.0K | $703.8K | $-30.2K | $31.8K | $24.2K | $7.4K | $13.0K | $24.0K | $51.0K | $42.0K | ||
| NET INCOME | ||||||||||||
| Net Income | $-331.4K | $-1.5M | $-908.6K | $-1.5M | $-2.4M | $-2.7M | $-7.4M | $-4.5M | $-7.1M | $-6.0M | ||
| Net Income (Continuing Operations) | $-331.4K | $-1.5M | $-908.6K | $-1.5M | $-2.4M | $-2.3M | $-7.4M | $-4.5M | $-7.1M | $-6.0M | ||
| Net Income (Discontinued Operations) | $-331.4K | $-1.5M | $-908.6K | $-1.5M | $-2.4M | $-2.7M | $-7.4M | $-4.5M | $-7.1M | $-6.0M | ||
| Net Income (Common Stockholders) | $-331.4K | $-1.5M | $-908.6K | $-1.5M | $-2.4M | $-2.7M | $-7.4M | $-4.5M | $-7.1M | $-6.0M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $-5.9M | ||
| TOTALS | ||||||||||||
| Total Expenses | $-5.6M | $-6.0M | $-6.7M | $-7.0M | $-7.6M | $9.1M | $14.7M | $23.4M | $12.6M | $11.8M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $944.0K | $953.3K | $1.0M | $1.1M | $1.2M | $1.3M | $1.5M | $1.6M | $1.8M | $16.8M | ||
| Average Shares Outstanding (Diluted) | $944.0K | $953.3K | $1.0M | $1.1M | $1.2M | $1.3M | $1.5M | $1.6M | $1.8M | $16.8M | ||
| Shares Outstanding | $948.1K | $1.0M | $1.1M | $1.1M | $1.2M | $1.5M | $3.1M | $1.7M | $2.1M | $2.5M | ||
| Basic EPS | $-0.32 | $-1.6 | $-0.88 | $-1.36 | $-2.08 | $-1.84 | $-4.32 | $-2.88 | $-4 | $-0.36 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | -- | $-1.84 | $-4.32 | $-2.88 | $-4 | $-0.36 | ||
| Diluted EPS | $-0.32 | $-1.6 | $-0.88 | $-1.36 | $-2.08 | $-1.84 | $-4.32 | $-2.88 | $-4 | $-0.36 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | -- | $-1.84 | $-4.32 | $-2.88 | $-4 | $-0.36 | ||
| OTHER METRICS | ||||||||||||
| Insurance And Claims | -- | -- | -- | -- | -- | -- | $6.7M | -- | -- | -- | ||
| Marketing Expense | -- | -- | -- | -- | -- | -- | $6.8M | $15.9M | -- | -- | ||
| Other Gand A | -- | -- | $-2.9K | -- | -- | $2.3M | $5.7M | $5.7M | $6.1M | $5.5M | ||
| Rent And Landing Fees | -- | -- | $-2.9K | -- | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $1.5M | $1.6M | $1.8M | $1.8M | $2.0M | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BMRA | $2.71 | -3.0% | 12.92K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |